In Mississippi, Medicaid Coverage of Weight Loss Drugs Fails To Catch On
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
The independent source for health policy research, polling, and news.
41 - 60 of 270 Results
In Mississippi, a state with one of the highest obesity rates in the nation, Medicaid covers weight loss drugs, but few enrollees have signed up for the benefit.
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated.
Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress — a potential tool for those with high trauma rates, like firefighters and police officers. Yet the drug’s stigma and unregulated marketplace leave first responders in uncharted territory.
People who maintained the nation’s land-based nuclear missile arsenal are coming down with similar cancers. The Air Force is wrapping up a large study of the health risks they may have faced.
North Carolina and Idaho are cutting their Medicaid programs to bridge budget gaps, raising fears that providers will stop taking patients and that hospitals will close even before the brunt of a new federal tax-and-budget law takes effect.
The Education Department’s civil rights office often intervenes when students face discrimination based on race, sex, religion, or disability and their families can’t resolve complaints locally. Parents fear the effort to gut the federal agency will leave them with nowhere to seek justice.
Many people don’t know they can fight a health insurance denial, let alone how to do it. Here are practical tips for consumers who want to appeal a prior authorization decision.
Conventional wisdom says GLP-1 drugs must be taken indefinitely to maintain weight loss. But a growing number of researchers, payers, and providers are challenging that consensus and exploring whether — and how — to taper patients off expensive GLP-1 drugs.
Four pediatricians said evidence-based science and medicine and a desire to keep kids healthy drive doctors’ childhood vaccination recommendations. And while pediatric practices might make money immunizing privately insured children, most practices likely break even or lose money from providing the shots.
About 90,000 people spent months in limbo as central Missouri’s major, and often only, provider fought over insurance contracts. Patients getting caught in the crossfire of disputes has become a familiar complication, as about 8% of hospitals have left an insurer network since 2021. Trump administration policies could accelerate the trend.
LGBTQ+ youth lost dedicated support on the 988 Suicide & Crisis Lifeline in July at a critical time. Advocates say mental health issues are rising in that population amid hostility from the Trump administration.
More than a dozen states are seeking their own versions of Medicaid work requirements. But the incoming federal standards pose questions around how much leeway states have to design their rules.
Native American groups declare that tribal sovereignty trumps state and federal efforts to restrict or ban gender-affirming care for two-spirit and LGBTQ+ tribal citizens. Tribes are analyzing the risk of opposing Trump’s policies, advocates say.
Amid increasingly frequent natural disasters, several states have turned to registries to prioritize help for vulnerable residents. But while some politicians see these registries as a potential solution to a public health problem, many disability advocates say they endanger residents with mobility problems by giving a false sense of security.
Billions in opioid settlement money was meant to be spent on treating and preventing addiction — but what happens if it’s misspent? Some advocates say attorneys general need to pay closer attention. If they don’t, a new tool might empower the public.
This installment of InvestigateTV and ϳԹ News’ “Costly Care” series explores how the type of medical facility where a patient seeks care can affect the cost of that care — particularly when that facility is a hospital.
In 2017, when President Donald Trump tried to repeal Obamacare and roll back Medicaid coverage, Republican governors helped turn Congress against it. Now, as Trump tries again to scale back Medicaid, Republican governors — whose constituents stand to lose federal funding and health coverage — have gone quiet on the health consequences.
A new vaccine advisory panel appointed by the HHS secretary, a longtime anti-vaccine activist, reflected his unsupported claims about the safety of childhood inoculations.
Health insurers issue millions of prior authorization denials every year, leaving many patients stuck in a convoluted appeals process, with little hope of meaningful policy change ahead. For doctors, these denials are frustrating and time-consuming. For patients, they can be devastating.
Rural hospitals would take an outsize hit from Republicans’ proposed cuts to Medicaid and other federal health programs. Researchers say the financial erosion would trigger hospital closures and service cuts, especially in communities where large shares of patients are enrolled in Medicaid.
© 2026 KFF